Skip to main content
Fig. 3 | Cell & Bioscience

Fig. 3

From: Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice

Fig. 3

Phloretin (PT) ameliorated hepatic steatosis in HFD-induced obese mice. a HE staining of liver tissues (200 × magnification). b Calculated number of lipid droplets in liver tissue. c Liver weight, d the ratio of liver weight to body weight and e NAFLD scores based on HE staining. f PT modulated the glycogen distribution based on PAS staining in the liver (200 × magnification). g PT increased glycogen levels and h modulated triglyceride (TG) and i total cholesterol (TC) levels in the liver tissue. Three independent experiments were analyzed and the data presented as the mean ± SEM; n = 10. *P < 0.05, **P < 0.01 compared to HFD-induced obesity. #P < 0.05, ##P < 0.01 compared to the Normal group

Back to article page